19.01.2015 Views

BOLETIN MARZO 2011 - SAMEFA

BOLETIN MARZO 2011 - SAMEFA

BOLETIN MARZO 2011 - SAMEFA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

marketing<br />

¿ COMO CAMBIAMOS LA IMAGEN <br />

Según el informe anual de Harris Interactive, sobre la imagen de las empresas a nivel<br />

popular, la industria farmacéutica es una de las menos populares, sufriendo incluso<br />

un descenso en el período 2008-2009.<br />

Positive ratings 2008 Positive ratings 2009 Change (2009-2008)<br />

% % %<br />

1. Technology 67 72 5<br />

2. Travel and Tourism 48 52 4<br />

3. Retail 43 52 9<br />

4. Consumer products 43 49 6<br />

5. Telecomunication 43 47 4<br />

6. Manufactoring 33 40 7<br />

7. Pharmaceutical 31 29 -2<br />

8. Energy/Utilities 29 33 4<br />

9. Airlines 23 24 1<br />

10. Insurance 22 23 1<br />

11. Automotive 16 25 9<br />

12. Tobacco 11 11 0<br />

13. Financial Services 11 16 5<br />

Fuente: Informe Anual Harris Interactive 2009.<br />

18<br />

TOP 15 EN GASTOS DE<br />

INVESTIGACIÓN<br />

Y DESARROLLO<br />

2009<br />

1. Roche - $8.7B<br />

2. Pfizer - $7.4B<br />

3. Novartis - $7.06B<br />

4. Johnson & Johnson - $6.66B<br />

5. Sanofi-Aventis<br />

- $6.25B<br />

6. GlaxoSmithKline - $5.59B<br />

7. Merck - $5.58B<br />

8. Takeda Pharmaceuticals - $4.64B<br />

9. AstraZeneca - $4.23B<br />

10. Eli Lilly - $4.13B<br />

11. Bristol-Myers Squibb - $3.48B<br />

12. Boehringer Ingelheim - $3.03B<br />

13. Abbott Laboratories - $2.61B<br />

14. Daiichi Sankyo - $1.89B<br />

15. Astellas Pharma - $1.63B

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!